HPR49 Formulary Inclusion for Oncologic Indications: Comparing FDA-Approved Indications and Off-Label Compendia Support
Abstract
Authors
Adam Zhu Mihir Mehta Kyle Clifton Mitun Patel
Adam Zhu Mihir Mehta Kyle Clifton Mitun Patel
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now